Introduction
Rheumatoid arthritis (RA) is a chronic, inflammatory disease that can lead to disability and significantly interfere with functional adaptation [1, 2] . Symptoms such as joint pain, swelling, and fatigue are disease-specific stressors that tax the adaptive resources of patients and heighten the risk for patient reported declines in function (i.e., difficulties in carrying out activities of daily living) as well as reports of emotional disturbance [3] which together create enormous psychological and financial loss for those afflicted [4] .
Given the salience of such subjective reports of declines in patients' physical, social, and psychological functioning, there is growing interest in using patient-reported outcomes (PROs) to assess treatment effectiveness [5] . PROs represent a patient's evaluation of his/her unique health status distinct from the evaluations of physicians and laboratory findings, and have a long history of use in the measurement of outcomes such as psychological distress, pain, and depression in patients with RA. Increasingly, PROs are being adopted as a mechanism for evaluating clinical efficacy in randomized clinical trials [6, 7] to allow for an analysis of whether treatments that are designed to reduce disease activity, for example, will also improve clinical functioning from the patient's perspective.
An important measure of PROs is health-related quality of life (HRQOL). While various definitions have been proposed, HRQOL generally refers to the ways in which a given health condition affects a patient's physical ability and capacity to function in a variety of social and emotional roles. HRQOL, which may be generic or diseasespecific, is generally divided into measures of physical functioning and emotional well-being [8] . In contrast to disability measures, which assess how health limits a patient's ability to perform specific tasks, HRQOL is a more global construct that indicates how well a patient is doing given the totality of his/her medical condition. Hence, the determinants of disability and HRQOL are likely to differ, as they are distinct constructs tapping different facets of functioning.
A key issue in HRQOL research in RA concerns the identification of variables, along with disease activity, that play prominent roles in Journal of Psychosomatic Research 71 (2011) 79-85 
